Product Description: Gambogic amide is a potent and selective agonist of TrkA and also induces its tyrosine phosphorylation and activation of downstream signaling, including Akt and MAPK. Gambogic amide specifically interacts with the cytoplasmic juxtamembrane domain of the TrkA receptor and triggers its dimerization, leading to activation. Gambogic amide has neuroprotective activity preventing glutamate-induced neuronal cell death. Gambogic amide has improved efficacy in a transient middle cerebral artery occlusion model of stroke and could be used to study neurodegenerative diseases and stroke[1].
Applications: Cancer-Kinase/protease
Formula: C38H45NO7
References: [1]Jang SW, et al. Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death. Proc Natl Acad Sci U S A. 2007 Oct 9;104(41):16329-34.
CAS Number: 286935-60-2
Molecular Weight: 627.77
Compound Purity: 98.0
Research Area: Cancer; Neurological Disease
Solubility: DMSO : 68 mg/mL (ultrasonic)
Target: Akt;ERK;Trk Receptor
Deutsch
English
